[
  {
    "id": 131,
    "question": "Case scenario of 1 day history of a patient with malignant MCA stroke next step (CT brain attached? 2/3 hypodensity without midline shift or hydrocephalus)",
    "option_a": "Hemicaniectomy",
    "option_b": "Osmotic therapy",
    "option_c": "ASA",
    "option_d": "Aspirin",
    "option_e": "Indications for hemicraniotomy",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nIn acute ischemic stroke management with IV tPA, several contraindications must be considered. One of the classical exclusions listed in many exam settings is that patients whose neurological deficits are rapidly improving (\u201crapid improvement\u201d) are often not given tPA, since many of these patients may continue to improve without intervention.\n\n**Pathophysiology**\n\ntPA works by catalyzing the conversion of plasminogen to plasmin, thereby dissolving thrombi. However, the risk-benefit ratio is optimized when deficits are significant and persistent. Rapid improvement may indicate spontaneous recanalization or minor deficits, reducing the expected benefit of thrombolysis while still exposing patients to hemorrhagic risk. Although other factors such as severe uncontrolled hypertension (e.g., systolic >185 mm Hg) are absolute contraindications unless controlled, many clinical protocols have historically listed rapid improvement as an exclusion criterion.\n\n**Clinical Correlation**\n\nPatients presenting with acute ischemic stroke are evaluated for eligibility for tPA. A patient whose neurological deficits improve rapidly may be observed rather than treated because the potential risks (such as hemorrhagic transformation) may outweigh the marginal benefit if the deficit is already resolving.\n\n**Diagnostic Approach**\n\nPrior to tPA administration, a full workup including noncontrast head CT (to exclude hemorrhage), blood pressure measurement, coagulation profile, and complete blood count (platelet count should be \u2265100,000/\u03bcL) is performed. The differential includes uncontrolled hypertension, bleeding diatheses, and mild strokes; each is evaluated for appropriateness for tPA use.\n\n**Management Principles**\n\nCurrent guidelines recommend tPA only if the benefits exceed the risks. The earliest step is to control blood pressure if it is elevated (using IV antihypertensives to bring it below 185/110 mm Hg). In cases of rapidly improving symptoms, many centers opt for observation rather than administering tPA. Note that if the patient\u2019s residual deficits are still disabling despite some improvement, many now consider tPA administration even in the setting of improvement. In pregnant or lactating patients, extra caution is taken to balance risks, and blood pressure management is critical before any intervention.\n\n**Option Analysis**\n\nOption A (BP >200): Although high blood pressure is a contraindication if not promptly controlled (with the standard threshold being >185/110 mm Hg), such elevations are frequently managed prior to tPA administration. Option B (Rapid improvement): Traditionally a contraindication since patients with rapidly improving symptoms (often non\u2010disabling) were excluded in major tPA trials. Option C (Platelets <150): The accepted threshold for platelets is <100,000/\u03bcL; values between 100,000 and 150,000 are not considered an absolute contraindication. Thus, option B is the intended answer in many board-style questions.\n\n**Clinical Pearls**\n\n\u2022 Rapid improvement does not always guarantee full recovery; however, if deficits become minimal and non-disabling, tPA may be withheld.  \u2022 Blood pressure must be below 185/110 mm Hg prior to tPA, but elevations can be pharmacologically controlled before treatment.\n\n**Current Evidence**\n\nRecent research indicates that the decision to exclude patients based solely on rapid improvement should be individualized since some patients with transient improvement may worsen. Nonetheless, many exam guidelines still list rapid improvement as an exclusion criterion for tPA eligibility.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "id": 132,
    "question": "Case scenario of a patient with acute onset weakness and pain & temperature loss, sparing vibration? Dx?",
    "option_a": "Spinal cord infarction",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nThe central concept here is recognition of an acute spinal cord lesion that produces a dissociated sensory loss\u2014specifically, loss of pain and temperature sensation due to involvement of the spinothalamic tracts, while sparing the dorsal columns which mediate vibration and proprioception. This pattern is classic for anterior spinal artery syndrome, a form of spinal cord infarction.\n\n**Pathophysiology**\n\nSpinal cord infarction typically results from occlusion of the anterior spinal artery, which supplies the anterior two-thirds of the spinal cord. This region includes not only the motor pathways but also the spinothalamic tracts, responsible for pain and temperature sensation. In contrast, the dorsal columns receive blood from the posterior spinal arteries, preserving vibratory and proprioceptive sensations.\n\n**Clinical Correlation**\n\nPatients often present acutely with weakness and a distinct pattern of sensory loss\u2014loss of pain and temperature with preserved vibration and proprioception below the level of the lesion. This presentation helps differentiate anterior spinal artery syndrome from other myelopathies, where both sensory modalities might be impaired.\n\n**Diagnostic Approach**\n\nKey differential diagnoses include anterior spinal artery syndrome (spinal cord infarction) versus conditions such as transverse myelitis, compressive myelopathy, or a syrinx (syringomyelia); however, the acute onset favors an ischemic etiology. MRI of the spine is the investigation of choice to confirm infarction in the anterior spinal cord and to rule out other compressive or inflammatory causes.\n\n**Management Principles**\n\nManagement of spinal cord infarction is largely supportive. This includes maintaining adequate blood pressure and oxygenation to optimize spinal cord perfusion. There is no definitive acute therapy; thrombolytic therapy is not standard in this context. In pregnant and lactating patients, careful attention must be paid to the safety of hemodynamic support medications and imaging techniques (preferably MRI without contrast when possible). Rehabilitation plays a crucial role in long-term recovery.\n\n**Option Analysis**\n\nThe presentation of acute onset weakness accompanied by loss of pain and temperature sensation with intact vibration points directly to an anterior cord lesion due to spinal cord infarction. Alternative possibilities like syringomyelia typically have a more insidious course and a 'cape-like' distribution of sensory loss, while inflammatory causes would not present as acutely.\n\n**Clinical Pearls**\n\nAcute onset dissociated sensory loss, where pain and temperature are impaired with intact proprioception and vibration, is a hallmark of anterior spinal artery syndrome. Prompt imaging is key to confirming the diagnosis and ruling out other causes. In all patients, including special populations such as pregnant or lactating individuals, a supportive management strategy is essential.\n\n**Current Evidence**\n\nCurrent guidelines emphasize early recognition and supportive care for spinal cord infarction. While ongoing research into neuroprotective strategies continues, treatment remains supportive and focused on rehabilitation. In managing pregnant or breastfeeding patients, clinicians should tailor supportive measures and imaging protocols to minimize fetal or neonatal risk.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "id": 133,
    "question": "Women after successful vaginal delivery complained of severe Headache, hemiparesis and her exam showed papilledema, what to do",
    "option_a": "CTV",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nIn postpartum women, especially after a vaginal delivery, the hypercoagulable state increases the risk for cerebral venous sinus thrombosis (CVT). CVT typically presents with severe headache, focal neurological deficits (such as hemiparesis), and signs of increased intracranial pressure (e.g., papilledema).\n\n**Pathophysiology**\n\nDuring the postpartum period, hormonal changes and a hypercoagulable state predispose women to thrombosis. In CVT, thrombus formation in the dural venous sinuses impairs venous drainage, resulting in increased venous pressure, cerebral edema, and potential hemorrhagic venous infarcts. Recent evidence emphasizes early diagnosis to mitigate brain injury.\n\n**Clinical Correlation**\n\nThe presentation of severe headache, hemiparesis, and papilledema in this patient is highly suspicious for CVT. Papilledema indicates raised intracranial pressure, while focal deficits (hemiparesis) suggest the presence of localized brain injury or infarction secondary to venous occlusion.\n\n**Diagnostic Approach**\n\nThe gold standard diagnostic tools include MR Venography and CT Venography (CTV). The latter is often more readily available and can quickly detect venous sinus occlusion. Differential diagnoses include intracranial hemorrhage, arterial stroke, post-dural puncture headache with neurological sequelae, and even eclampsia, which must be differentiated based on imaging and clinical history.\n\n**Management Principles**\n\nFirst-line management for CVT is anticoagulation, typically with low molecular weight heparin even in the presence of small hemorrhagic infarcts. Subsequent therapies include transitioning to oral anticoagulants for long-term management. In pregnancy or lactation, LMWH is preferred due to its safety profile for both the mother and the infant. Supportive care, management of intracranial pressure, and monitoring for neurological deterioration are essential.\n\n**Option Analysis**\n\nOption A (CTV) is appropriate because CT Venography is a rapid, accessible imaging modality to evaluate the cerebral venous system. While MR Venography is also highly sensitive, CTV is a correct choice, especially in an acute setting. The other options (B, C, D) were not provided, but they likely represent less optimal or unrelated imaging techniques.\n\n**Clinical Pearls**\n\n1) Always suspect CVT in postpartum women presenting with headache and neurological deficits. 2) Papilledema is a key indicator of increased intracranial pressure and should prompt urgent imaging. 3) Early diagnosis with CTV or MRV improves outcomes by enabling prompt anticoagulation.\n\n**Current Evidence**\n\nRecent guidelines from neurology and stroke associations underscore the importance of early imaging with CT or MR Venography for suspected CVT. Studies continue to support the safety and efficacy of early anticoagulation even in the presence of minor hemorrhagic changes.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "id": 134,
    "question": "Patient came with a CT brain attached unilateral occipital stroke, asked about which artery? (According to picture)",
    "option_a": "PCA",
    "option_b": "SCA",
    "option_c": "PICA",
    "option_d": "MCA",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nThe occipital lobe is primarily supplied by the posterior cerebral artery (PCA). Infarctions in this region most commonly result from occlusion of the PCA, leading to visual deficits.\n\n**Pathophysiology**\n\nAn occlusion in the PCA causes ischemia in the occipital cortex. The resulting infarction typically affects the primary visual processing areas, leading to characteristic visual field deficits such as contralateral homonymous hemianopia with possible macular sparing. Current research supports the role of rapid reperfusion therapies in minimizing infarct size.\n\n**Clinical Correlation**\n\nPatients with a PCA stroke usually present with visual disturbances \u2013 most notably, a loss of the contralateral visual field. The CT image showing a unilateral occipital stroke is consistent with PCA territory involvement. This distinguishes it from other strokes that affect motor or sensory cortices.\n\n**Diagnostic Approach**\n\nImaging via CT and magnetic resonance imaging (MRI) can help identify the infarct location. Differential diagnoses include strokes in the middle cerebral artery (MCA) territory (which typically present with motor and sensory deficits), and those in the cerebellar regions (supplied by the SCA or PICA), which present with coordination issues.\n\n**Management Principles**\n\nThe management of an acute PCA stroke includes intravenous thrombolysis if the patient presents within the therapeutic window, followed by antiplatelet agents. Mechanical thrombectomy is considered in select cases based on the size and occlusion site. In pregnant or lactating women, thrombolysis may still be considered after careful risk\u2010benefit assessment, while antiplatelet management should consider safety for the fetus or neonate.\n\n**Option Analysis**\n\nOption A (PCA) is correct because the occipital lobe is vascularized by the posterior cerebral artery. Option B (SCA) and Option C (PICA) supply cerebellar regions, and Option D (MCA) supplies the lateral aspects of the cerebral hemispheres, which typically do not include the occipital lobe.\n\n**Clinical Pearls**\n\n1) Occipital strokes most commonly result in visual field deficits like homonymous hemianopia. 2) Macular sparing is a classic finding in PCA strokes due to collateral blood supply. 3) Timely reperfusion therapy is pivotal in preserving visual function.\n\n**Current Evidence**\n\nRecent updates in stroke guidelines emphasize the window for thrombolysis and detail criteria for mechanical thrombectomy. Advanced imaging techniques are increasingly used to guide individualized management plans.",
    "exam_year": "2021",
    "exam_type": "Part I",
    "image_url": "page_39.png"
  },
  {
    "id": 135,
    "question": "Patient post carotid stent or endarterectomy (not sure) Came with altered level of conscious, CT attached (small Right frontal cortical hemorrhage)",
    "option_a": "hyperperfusion syndrome",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nHyperperfusion syndrome is a known complication following carotid revascularization procedures such as stenting or endarterectomy. It occurs due to impaired cerebral autoregulation in chronically hypoperfused brain regions.\n\n**Pathophysiology**\n\nAfter carotid revascularization, the sudden restoration of blood flow can overwhelm the distal vasculature that has adapted to a lower perfusion state. The loss of autoregulation leads to excessive cerebral blood flow, which in turn can cause blood\u2013brain barrier disruption, vasogenic edema, and even small hemorrhages, as seen in the CT image (small right frontal cortical hemorrhage).\n\n**Clinical Correlation**\n\nPatients typically present within days following the procedure with symptoms ranging from headache and altered mental status to seizures. In this case, the altered level of consciousness and CT findings are consistent with hyperperfusion syndrome.\n\n**Diagnostic Approach**\n\nDiagnosis is primarily clinical, supported by imaging findings. Differential diagnoses include embolic stroke, reperfusion injury, and hemorrhagic transformation of an ischemic infarct. A detailed review of the procedural history and blood pressure control is essential.\n\n**Management Principles**\n\nThe cornerstone of management is strict blood pressure control using IV antihypertensives (e.g., labetalol, nicardipine). In addition, supportive care and neurological monitoring are key. For patients who are pregnant or lactating, antihypertensive choices should be guided by safety profiles (e.g., labetalol is generally considered safe during pregnancy). Early recognition and aggressive blood pressure management are critical to prevent further neurological deterioration.\n\n**Option Analysis**\n\nOption A (hyperperfusion syndrome) is correct given the clinical context of recent carotid intervention, altered mental status, and the imaging findings of a small cortical hemorrhage. Other options, which were not provided, likely pertain to alternative causes of post-procedural complications but do not fit the described presentation.\n\n**Clinical Pearls**\n\n1) Post-carotid revascularization, any sudden neurological deterioration should raise suspicion for hyperperfusion syndrome. 2) Strict blood pressure control is essential in the immediate postoperative period to minimize the risk of reperfusion injury. 3) Early imaging is key to differentiating between hyperperfusion syndrome and embolic events.\n\n**Current Evidence**\n\nRecent studies highlight the importance of individualized blood pressure targets post-revascularization and reinforce early detection protocols for hyperperfusion syndrome. Updated guidelines recommend the use of IV antihypertensive agents with a favorable safety profile in sensitive populations including pregnant women.",
    "exam_year": "2021",
    "exam_type": "Part I"
  },
  {
    "id": 136,
    "question": "Elderly female brought to ER with \u2193 level of consciousness. Unknown history. Her labs showed INR of 3. Brain CT attached. What is the best next step?",
    "option_a": "vitamin K",
    "option_b": "PCC",
    "option_c": "idarucizumab",
    "option_d": "FFP",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nIn patients with intracranial hemorrhage associated with anticoagulation therapy, immediate reversal of the coagulopathy is the primary goal. Elevated INR suggests a warfarin-related bleed, and prompt reversal is imperative.\n\n**Pathophysiology**\n\nWarfarin acts by inhibiting vitamin K-dependent clotting factors (II, VII, IX, and X). An elevated INR indicates that the clotting cascade is impaired, thereby predisposing to bleeding. Prothrombin complex concentrate (PCC) rapidly supplies the deficient clotting factors, offering faster normalization of coagulation compared to vitamin K alone.\n\n**Clinical Correlation**\n\nThe elderly female with a decreased level of consciousness, an INR of 3, and a brain CT revealing hemorrhage is most consistent with warfarin-associated intracranial hemorrhage. In such emergencies, immediate correction of the INR is crucial to prevent hematoma expansion and further neurological decline.\n\n**Diagnostic Approach**\n\nDiagnosing warfarin-associated intracranial hemorrhage involves a combination of clinical evaluation and imaging studies. Differential diagnoses include hemorrhage from other causes such as amyloid angiopathy or traumatic brain injury. A careful review of the medication history and laboratory values (INR) is essential.\n\n**Management Principles**\n\nThe first-line management in warfarin-related ICH involves rapid reversal of anticoagulation. The current guidelines favor four-factor prothrombin complex concentrate (PCC) due to its rapid onset of action. Vitamin K (typically 10 mg IV) should be administered concurrently to ensure sustained reversal, as its effect takes several hours. Although Fresh Frozen Plasma (FFP) is an option, it is generally less preferred because of slower correction, risk of volume overload, and preparation delays. In pregnancy or lactation, vitamin K is considered safe; however, the use of PCC should be carefully weighed as data are more limited in these populations, though the life\u2010threatening nature of hemorrhage necessitates rapid intervention.\n\n**Option Analysis**\n\nOption A (vitamin K) is important but inadequate as a monotherapy in an emergency because its effect is delayed. Option B (PCC) is correct because it rapidly corrects the coagulopathy, which is critical in the setting of intracranial hemorrhage. Option C (idarucizumab) is an antidote for dabigatran, not warfarin. Option D (FFP) is a viable alternative but is less favored compared to PCC in terms of speed and efficacy.\n\n**Clinical Pearls**\n\n1) In warfarin-associated ICH, rapid reversal of anticoagulation is critical; PCC is preferred over FFP due to its speed and efficiency. 2) Always administer vitamin K alongside PCC to maintain reversal of coagulopathy. 3) Always consider the type of anticoagulant when selecting the reversal agent (e.g., idarucizumab is specific for dabigatran).\n\n**Current Evidence**\n\nRecent guidelines and studies from stroke and neurocritical care societies emphasize the urgent use of four-factor PCC for the management of warfarin-associated intracranial hemorrhage. Ongoing research continues to refine protocols to minimize hematoma expansion and improve outcomes, with a growing body of evidence supporting PCC over FFP due to faster and more reliable correction of INR.",
    "exam_year": "2022",
    "exam_type": "Part I",
    "image_url": "page_2.png"
  },
  {
    "id": 137,
    "question": "57 years old male, DM, HTN, DLP, smoker, admitted under stroke with left sided weakness and facial asymmetry. Brain CT: right capsular infarction. Brain CTA: significant intracranial ICA stenosis. What is the best management?",
    "option_a": "medical therapy",
    "option_b": "ICA stenting",
    "option_c": "ICA endarterectomy",
    "option_d": "craniotomy",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nThis case focuses on a patient with an acute ischemic stroke secondary to intracranial atherosclerotic disease. Intracranial ICA stenosis (as opposed to extracranial disease) is best managed medically rather than with surgical or endovascular interventions.\n\n**Pathophysiology**\n\nRisk factors such as diabetes, hypertension, dyslipidemia, and smoking contribute to atherosclerotic plaque formation within the intracranial vessels. The plaque can narrow the lumen of the artery, reducing cerebral blood flow and leading to infarction, as seen in the right capsular region in this patient.\n\n**Clinical Correlation**\n\nThe patient\u2019s presentation with left\u2010sided weakness and facial asymmetry correlates with an infarction in the right basal ganglia/capsular region. The brain CT confirms an established infarct while the CTA reveals significant stenosis of the intracranial ICA, which is the likely culprit lesion.\n\n**Diagnostic Approach**\n\nStandard evaluation includes non\u2010contrast CT to rule out hemorrhage and CT angiography (CTA) to visualize the vascular anatomy. Differential diagnoses include small vessel lacunar infarcts due to chronic hypertension versus embolic strokes from other sources; however, the CTA findings of significant focal stenosis point to a large vessel etiology.\n\n**Management Principles**\n\nAccording to current guidelines (e.g., SAMMPRIS trial), the first\u2010line management for patients with intracranial stenosis is aggressive medical therapy. This includes antiplatelet therapy (often dual therapy initially), high\u2010dose statins, and rigorous risk factor modification (blood pressure control, glycemic control, lipid management, smoking cessation). In pregnancy and lactation, medications must be chosen carefully \u2013 for instance, aspirin and certain statins have specific guidelines regarding use; risk\u2013benefit assessments are crucial when managing cardiovascular risk factors in pregnant or breastfeeding patients.\n\n**Option Analysis**\n\nA: Medical therapy \u2013 Correct. B: ICA stenting \u2013 Typically considered for extracranial lesions and has a high periprocedural risk in intracranial disease. C: ICA endarterectomy \u2013 Also reserved for extracranial carotid stenosis. D: Craniotomy \u2013 Not indicated for ischemic stroke due to atherosclerotic disease.\n\n**Clinical Pearls**\n\n1. Intracranial atherosclerotic disease is managed conservatively with aggressive medical therapy. 2. Risk factor modification is essential to prevent recurrence. 3. Interventional approaches are generally reserved for refractory cases.\n\n**Current Evidence**\n\nRecent trials (SAMMPRIS and VISSIT) have demonstrated that optimal medical therapy is superior to interventional procedures in patients with intracranial atherosclerotic disease. Guidelines continue to emphasize intensive control of vascular risk factors and the use of antiplatelet/antithrombotic therapy as the mainstay of treatment.",
    "exam_year": "2022",
    "exam_type": "Part I",
    "image_url": "page_2.png"
  },
  {
    "id": 138,
    "question": "36 years old female referred to neurology clinic for issues with forgetting the events. She has chronic migraine headache and had suffered stroke in the past. Her father died at age of 65 with dementia. Brain MRI: subcortical WM changes likely microvascular lacunes. DX?",
    "option_a": "Moyamoya",
    "option_b": "MELAS",
    "option_c": "CADASIL",
    "option_d": "Susac disease",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nThis case focuses on a patient with an acute ischemic stroke secondary to intracranial atherosclerotic disease. Intracranial ICA stenosis (as opposed to extracranial disease) is best managed medically rather than with surgical or endovascular interventions.\n\n**Pathophysiology**\n\nRisk factors such as diabetes, hypertension, dyslipidemia, and smoking contribute to atherosclerotic plaque formation within the intracranial vessels. The plaque can narrow the lumen of the artery, reducing cerebral blood flow and leading to infarction, as seen in the right capsular region in this patient.\n\n**Clinical Correlation**\n\nThe patient\u2019s presentation with left\u2010sided weakness and facial asymmetry correlates with an infarction in the right basal ganglia/capsular region. The brain CT confirms an established infarct while the CTA reveals significant stenosis of the intracranial ICA, which is the likely culprit lesion.\n\n**Diagnostic Approach**\n\nStandard evaluation includes non\u2010contrast CT to rule out hemorrhage and CT angiography (CTA) to visualize the vascular anatomy. Differential diagnoses include small vessel lacunar infarcts due to chronic hypertension versus embolic strokes from other sources; however, the CTA findings of significant focal stenosis point to a large vessel etiology.\n\n**Management Principles**\n\nAccording to current guidelines (e.g., SAMMPRIS trial), the first\u2010line management for patients with intracranial stenosis is aggressive medical therapy. This includes antiplatelet therapy (often dual therapy initially), high\u2010dose statins, and rigorous risk factor modification (blood pressure control, glycemic control, lipid management, smoking cessation). In pregnancy and lactation, medications must be chosen carefully \u2013 for instance, aspirin and certain statins have specific guidelines regarding use; risk\u2013benefit assessments are crucial when managing cardiovascular risk factors in pregnant or breastfeeding patients.\n\n**Option Analysis**\n\nA: Medical therapy \u2013 Correct. B: ICA stenting \u2013 Typically considered for extracranial lesions and has a high periprocedural risk in intracranial disease. C: ICA endarterectomy \u2013 Also reserved for extracranial carotid stenosis. D: Craniotomy \u2013 Not indicated for ischemic stroke due to atherosclerotic disease.\n\n**Clinical Pearls**\n\n1. Intracranial atherosclerotic disease is managed conservatively with aggressive medical therapy. 2. Risk factor modification is essential to prevent recurrence. 3. Interventional approaches are generally reserved for refractory cases.\n\n**Current Evidence**\n\nRecent trials (SAMMPRIS and VISSIT) have demonstrated that optimal medical therapy is superior to interventional procedures in patients with intracranial atherosclerotic disease. Guidelines continue to emphasize intensive control of vascular risk factors and the use of antiplatelet/antithrombotic therapy as the mainstay of treatment.",
    "exam_year": "2022",
    "exam_type": "Part I",
    "image_url": "page_2.png"
  },
  {
    "id": 139,
    "question": "Case scenario of patient admitted with subarachnoid hemorrhage. After 2 days he was lethargic, BP 104/52, serum Na 123, \u2191 urine Na and urine osmolality. What is the best next step in management?",
    "option_a": "fluid restriction",
    "option_b": "fluid hydration",
    "option_c": "mannitol",
    "option_d": "oral Na tablet",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nThis case focuses on a patient with an acute ischemic stroke secondary to intracranial atherosclerotic disease. Intracranial ICA stenosis (as opposed to extracranial disease) is best managed medically rather than with surgical or endovascular interventions.\n\n**Pathophysiology**\n\nRisk factors such as diabetes, hypertension, dyslipidemia, and smoking contribute to atherosclerotic plaque formation within the intracranial vessels. The plaque can narrow the lumen of the artery, reducing cerebral blood flow and leading to infarction, as seen in the right capsular region in this patient.\n\n**Clinical Correlation**\n\nThe patient\u2019s presentation with left\u2010sided weakness and facial asymmetry correlates with an infarction in the right basal ganglia/capsular region. The brain CT confirms an established infarct while the CTA reveals significant stenosis of the intracranial ICA, which is the likely culprit lesion.\n\n**Diagnostic Approach**\n\nStandard evaluation includes non\u2010contrast CT to rule out hemorrhage and CT angiography (CTA) to visualize the vascular anatomy. Differential diagnoses include small vessel lacunar infarcts due to chronic hypertension versus embolic strokes from other sources; however, the CTA findings of significant focal stenosis point to a large vessel etiology.\n\n**Management Principles**\n\nAccording to current guidelines (e.g., SAMMPRIS trial), the first\u2010line management for patients with intracranial stenosis is aggressive medical therapy. This includes antiplatelet therapy (often dual therapy initially), high\u2010dose statins, and rigorous risk factor modification (blood pressure control, glycemic control, lipid management, smoking cessation). In pregnancy and lactation, medications must be chosen carefully \u2013 for instance, aspirin and certain statins have specific guidelines regarding use; risk\u2013benefit assessments are crucial when managing cardiovascular risk factors in pregnant or breastfeeding patients.\n\n**Option Analysis**\n\nA: Medical therapy \u2013 Correct. B: ICA stenting \u2013 Typically considered for extracranial lesions and has a high periprocedural risk in intracranial disease. C: ICA endarterectomy \u2013 Also reserved for extracranial carotid stenosis. D: Craniotomy \u2013 Not indicated for ischemic stroke due to atherosclerotic disease.\n\n**Clinical Pearls**\n\n1. Intracranial atherosclerotic disease is managed conservatively with aggressive medical therapy. 2. Risk factor modification is essential to prevent recurrence. 3. Interventional approaches are generally reserved for refractory cases.\n\n**Current Evidence**\n\nRecent trials (SAMMPRIS and VISSIT) have demonstrated that optimal medical therapy is superior to interventional procedures in patients with intracranial atherosclerotic disease. Guidelines continue to emphasize intensive control of vascular risk factors and the use of antiplatelet/antithrombotic therapy as the mainstay of treatment.",
    "exam_year": "2022",
    "exam_type": "Part I"
  },
  {
    "id": 140,
    "question": "Young girl with congenital heart disease presented with fever and right sided weakness. She has signs of stroke on examination. What is the best diagnostic test?",
    "option_a": "Blood culture",
    "option_b": "Brain CT",
    "option_c": "Contrasted brain CT",
    "option_d": "LP",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nIn an acute stroke scenario, rapid neuroimaging is critical. A noncontrast CT scan is the standard initial test to rapidly differentiate between ischemic and hemorrhagic stroke, which is essential for guiding emergent management. In a young patient with congenital heart disease and fever, septic embolism from possible infective endocarditis is a concern, but the immediate priority is to evaluate the brain for stroke.\n\n**Pathophysiology**\n\nPatients with congenital heart disease are at increased risk for infective endocarditis. Vegetations on the valves can embolize, causing septic emboli that lead to ischemic infarcts (and sometimes hemorrhagic conversion) in the brain. Identification of such infarcts is best achieved initially through brain imaging.\n\n**Clinical Correlation**\n\nThe patient\u2019s presentation with fever and right-sided weakness suggests an embolic stroke, potentially from infective endocarditis. While the fever urges evaluation for an infectious source (with blood cultures and echocardiography), the neurological deficits require immediate brain imaging to determine the nature of the stroke.\n\n**Diagnostic Approach**\n\nThe initial evaluation of stroke involves a noncontrast CT scan of the brain to rapidly rule out hemorrhage and confirm ischemic stroke. Differential diagnoses include septic embolic stroke, primary hemorrhagic stroke, brain abscess, and other central nervous system infections. Blood cultures, while crucial for diagnosing infective endocarditis, do not address the immediate need to characterize the stroke.\n\n**Management Principles**\n\nAccording to current stroke guidelines, the rapid assessment of stroke via a noncontrast brain CT scan is paramount to determine therapeutic options, including potential thrombolysis. In cases where infective endocarditis is suspected, adjunctive tests such as blood cultures and echocardiography are performed subsequently. In pregnancy or lactation, noncontrast CT can be performed with appropriate fetal shielding, as it minimizes radiation exposure and is still considered the imaging modality of choice in the acute setting.\n\n**Option Analysis**\n\nOption A (Blood culture) is critical for diagnosing the underlying infective cause but is not the best test to evaluate acute neurological deficits. Option D (Lumbar puncture) is contraindicated in the setting of stroke due to the risk of herniation if intracranial pressure is elevated. Option C (Contrasted brain CT) is not the first-line imaging modality since the use of contrast can obscure the distinction between hemorrhage and ischemic areas in the acute stroke setting. Option B (Brain CT), understood as noncontrast CT, is the appropriate and immediate test for stroke evaluation.\n\n**Clinical Pearls**\n\n\u2022 In the acute evaluation of stroke, always prioritize a noncontrast head CT to differentiate hemorrhagic from ischemic stroke quickly. \u2022 In patients with congenital heart disease presenting with fever and stroke signs, septic emboli secondary to infective endocarditis should be suspected. \u2022 While blood cultures and echocardiography are essential for diagnosing infective endocarditis, they follow the urgent imaging required to manage acute neurological deficits.\n\n**Current Evidence**\n\nGuidelines from the American Heart Association (AHA) and the American Stroke Association consistently recommend noncontrast CT as the first-line imaging modality in suspected stroke cases due to its speed, accessibility, and ability to reliably detect hemorrhage. Recent studies reinforce that even when infective endocarditis is in the differential, immediate brain imaging is essential for stroke management and is not altered by the need for subsequent infectious work-up.",
    "exam_year": "2022",
    "exam_type": "Part I"
  }
]